Quick Takeaways
- Yap Kim Choy filed SCHEDULE 13G for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC).
- Disclosed ownership: 9.8%.
- Date of event: 28 Jul 2025.
Yap Kim Choy - 28 Jul 2025 SCHEDULE 13G Report for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC)
- Filing Manager
- Yap Kim Choy
- Reporting Manager
- Yap Kim Choy
- Symbol
- CYCC
- Shares outstanding
- 2,224,490 shares
- Disclosed Ownership
- 218,000 shares
- Ownership
- 9.8%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Aug 2025, 10:12:56 UTC
- Date of event
- 28 Jul 2025
- Next filing
- 02 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Yap Kim Choy disclosed 9.8% ownership in Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC) on 28 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Aug 2025, 10:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Yap Kim Choy | 9.8% | 218,000 | 218,000 | 0 | /s/ Yap Kim Choy | Yap Kim Choy |